ARTICLE | Company News
Novelix, University of Southern California deal
January 2, 2006 8:00 AM UTC
The university granted Novelix an exclusive license to a group of small molecule cancer therapeutics. The lead product is NVX-144, an IL-24 modulator that is in preclinical development. ...